The adenosine triphosphate (ATP)–sensitive K+ (KATP) channel is the most abundant K+ channel active in the skeletal muscle fibers of humans and animals. In the present work, we demonstrate the involvement of the muscular KATP channel in a skeletal muscle disorder known as hypokalemic periodic paralysis (HOPP), which is caused by mutations of the dihydropyridine receptor of the Ca2+ channel. Muscle biopsies excised from three patients with HOPP carrying the R528H mutation of the dihydropyridine receptor showed a reduced sarcolemma KATP current that was not stimulated by magnesium adenosine diphosphate (MgADP; 50–100 μM) and was partially restored by cromakalim. In contrast, large KATP currents stimulated by MgADP were recorded in the healthy subjects. At channel level, an abnormal KATP channel showing several subconductance states was detected in the patients with HOPP. None of these were surveyed in the healthy subjects. Transitions of the KATP channel between subconductance states were also observed after in vitro incubation of the rat muscle with low-K+ solution. The lack of the sarcolemma KATP current observed in these patients explains the symptoms of the disease, i.e., hypokalemia, depolarization of the fibers, and possibly the paralysis following insulin administration.
Domenico Tricarico, Serenella Servidei, Pietro Tonali, Karin Jurkat-Rott, Diana Conte Camerino
Title and authors | Publication | Year |
---|---|---|
Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent KATP Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome
Scala R, Maqoud F, McClenaghan C, Harter TM, Perrone MG, Scilimati A, Nichols CG, Tricarico D |
Cells | 2023 |
Exercise and fatigue: integrating the role of K(+), Na(+) and Cl(-) in the regulation of sarcolemmal excitability of skeletal muscle.
Renaud JM, Ørtenblad N, McKenna MJ, Overgaard K |
European Journal of Applied Physiology | 2023 |
Consequences of SUR2[A478V] Mutation in Skeletal Muscle of Murine Model of Cantu Syndrome
R Scala, F Maqoud, N Zizzo, G Passantino, A Mele, GM Camerino, C McClenaghan, TM Harter, CG Nichols, D Tricarico |
Cells | 2021 |
Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K+ Channels: Role in the Adverse Drug Reactions
F Maqoud, R Scala, V Tragni, CL Pierri, MG Perrone, A Scilimati, D Tricarico |
Pharmaceutics | 2021 |
Pathophysiological Consequences of KATP Channel Overactivity and Pharmacological Response to Glibenclamide in Skeletal Muscle of a Murine Model of Cantù Syndrome
R Scala, F Maqoud, N Zizzo, A Mele, GM Camerino, FA Zito, G Ranieri, C McClenaghan, TM Harter, CG Nichols, D Tricarico |
Frontiers in pharmacology | 2020 |
Molecular structure and function of big calcium-activated potassium channels in skeletal muscle: pharmacological perspectives
F Maqoud, M Cetrone, A Mele, D Tricarico |
Physiological genomics | 2017 |
ATP Sensitive Potassium Channels in the Skeletal Muscle Function: Involvement of the KCNJ11(Kir6.2) Gene in the Determination of Mechanical Warner Bratzer Shear Force
D Tricarico, M Selvaggi, G Passantino, PD Palo, C Dario, P Centoducati, A Tateo, A Curci, F Maqoud, A Mele, GM Camerino, A Liantonio, P Imbrici, N Zizzo |
Frontiers in physiology | 2016 |
Potassium dependent rescue of Central Core Disease in mouse
Martin Hanson, Jonathan Wilde, Rosa Moreno, Angela Minic, Lee Niswander |
eLife | 2015 |
Comprehensive Physiology
SC Cannon |
Comprehensive Physiology | 2015 |
Pathologies of Calcium Channels
N Weiss, A Koschak |
2013 | |
A Calcium Channel Knock-In Mutant (CaV1.1-R528H)Mouse Model of Hypokalemic Periodic Paralysis
Fenfen Wu, Wentao Mi, Erick Hernández-Ochoa, Dennis Burns, Yu Fu, Hillery Gray, Arie Struyk, Martin F. Schneider, Stephen C. Cannon |
Journal of Clinical Investigation | 2012 |
Brenner and Rector's The Kidney
C Brugnara, KU Eckardt |
Brenner and Rector's The Kidney | 2012 |
Advances in Cardiac ATP-Sensitive K + Channelopathies From Molecules to Populations
A Terzic, AE Alekseev, S Yamada, S Reyes, TM Olson |
Circulation. Arrhythmia and electrophysiology | 2011 |
Recent advances in the pathogenesis and drug action in periodic paralyses and related channelopathies
D Tricarico, DC Camerino |
Frontiers in pharmacology | 2011 |
Novel etiopathophysiological aspects of thyrotoxic periodic paralysis
RM Maciel, SC Lindsey, MR da Silva |
Nature Reviews Endocrinology | 2011 |
Hypokalemic periodic paralysis; two different genes responsible for similar clinical manifestations
H Kim, H Hwang, HI Cheong, HW Park |
Korean Journal of Pediatrics | 2011 |
Skeletal Muscle Na+ Channel Disorders
D Simkin, S Bendahhou |
Frontiers in pharmacology | 2011 |
Voltage-sensor mutations in channelopathies of skeletal muscle
SC Cannon |
The Journal of Physiology | 2010 |
Sodium channelopathies of skeletal muscle result from gain or loss of function
K Jurkat-Rott, B Holzherr, M Fauler, F Lehmann-Horn |
Pflügers Archiv : European journal of physiology | 2010 |
Muscle channelopathies: does the predicted channel gating pore offer new treatment insights for hypokalaemic periodic paralysis?
E Matthews, MG Hanna |
The Journal of Physiology | 2010 |
Expression Pattern of Kir6.2 in Skeletal Muscle Cells of Patients with Familial Hypokalemic Periodic Paralysis
SJ Kim, DH Yoon, JB Kim |
Journal of Life Science | 2010 |
Reduced expression and abnormal localization of the KATP channel subunit SUR2A in patients with familial hypokalemic periodic paralysis
SJ Kim, YJ Lee, JB Kim |
Biochemical and Biophysical Research Communications | 2010 |
INa and IKir are reduced in Type 1 hypokalemic and thyrotoxic periodic paralysis
A Puwanant, RL Ruff |
Muscle & Nerve | 2010 |
The K ATP channel is a molecular sensor of atrophy in skeletal muscle: K ATP channel and muscle atrophy
D Tricarico, A Mele, GM Camerino, R Bottinelli, L Brocca, A Frigeri, M Svelto, AL George, DC Camerino |
The Journal of Physiology | 2010 |
Human K(ATP) channelopathies: diseases of metabolic homeostasis
TM Olson, A Terzic |
Pflügers Archiv : European journal of physiology | 2009 |
The role of CACNA1Sin predisposition to malignant hyperthermia
D Carpenter, C Ringrose, V Leo, A Morris, RL Robinson, PJ Halsall, PM Hopkins, MA Shaw |
BMC Medical Genetics | 2009 |
Terapia delle malattie neurologiche
A Sghirlanzoni |
2009 | |
Treatment of neuromuscular channelopathies: Current concepts and future prospects
JC Cleland, RC Griggs |
Neurotherapeutics | 2008 |
Primary periodic paralyses
J Finsterer |
Acta Neurologica Scandinavica | 2008 |
A patient suffering from hypokalemic periodic paralysis is deficient in skeletal muscle ATP-sensitive K channels
S Jovanović, Q Du, S Mukhopadhyay, R Swingler, R Buckley, J McEachen, A Jovanović |
Clinical and Translational Science | 2008 |
An Arg1239His mutation of the CACNL1A3 gene in a Korean family with hypokalemic periodic paralysis
CY Yeo, YO Kim, MK Kim, JY Kim, YK Cho, CJ Kim, YJ Woo |
Korean Journal of Pediatrics | 2008 |
Acetazolamide prevents vacuolar myopathy in skeletal muscle of K+-depleted rats
D Tricarico, S Lovaglio, A Mele, G Rotondo, E Mancinelli, G Meola, DC Camerino |
British Journal of Pharmacology | 2008 |
Contractile dysfunctions in ATP-dependent K + channel-deficient mouse muscle during fatigue involve excessive depolarization and Ca 2+ influx through L-type Ca 2+ channels: Ca 2+ influx in K ATP channel-deficient muscle
C Cifelli, L Boudreault, B Gong, JP Bercier, JM Renaud |
Experimental Physiology | 2008 |
Molecular Determinants for the Activating/Blocking Actions of the 2H-1,4-Benzoxazine Derivatives, a Class of Potassium Channel Modulators Targeting the Skeletal Muscle KATP Channels
D Tricarico, A Mele, GM Camerino, A Laghezza, G Carbonara, G Fracchiolla, P Tortorella, F Loiodice, DC Camerino |
Molecular pharmacology | 2008 |
Electrical Diseases of the Heart
I Gussak, C Antzelevitch, AA Wilde, PA Friedman, MJ Ackerman, WK Shen |
2008 | |
Reduced expression of Kir6.2/SUR2A subunits explains KATP deficiency in K+-depleted rats
D Tricarico, A Mele, B Liss, FM Ashcroft, AL Lundquist, RR Desai, AL George, DC Camerino |
Neuromuscular Disorders | 2007 |
Calcium Signalling and Disease
E Carafoli, M Brini |
Subcellular Biochemistry | 2007 |
Hypokalemic periodic paralysis: A model for a clinical and research approach to a rare disorder
B Fontaine, E Fournier, D Sternberg, S Vicart, N Tabti |
Neurotherapeutics | 2007 |
PATHOMECHANISMS IN CHANNELOPATHIES OF SKELETAL MUSCLE AND BRAIN
SC Cannon |
Annual Review of Neuroscience | 2006 |
Hybrid assemblies of ATP-sensitive K+ channels determine their muscle-type-dependent biophysical and pharmacological properties
D Tricarico, A Mele, AL Lundquist, RR Desai, AL George, DC Camerino |
Proceedings of the National Academy of Sciences | 2006 |
Mutation screening in Chinese hypokalemic periodic paralysis patients
W Wang, L Jiang, L Ye, N Zhu, T Su, L Guan, X Li, G Ning |
Molecular Genetics and Metabolism | 2006 |
Sour on the inside, calm on the outside: How acetazolamide may stabilize membrane excitability
RL Ruff |
Muscle & Nerve | 2006 |
Gene analysis of the calcium channel 1 subunit and clinical studies for two patients with hypokalemic periodic paralysis
K Kageyama, K Terui, S Tsutaya, E Matsuda, M Shoji, S Sakihara, T Nigawara, S Takayasu, T Moriyama, M Yasujima, T Suda |
Journal of Endocrinological Investigation | 2006 |
Voltage-gated calcium channels in genetic diseases
I Bidaud, A Mezghrani, LA Swayne, A Monteil, P Lory |
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research | 2006 |
Paresis
S Dave-Sharma, J Sharma |
Clinical Pediatrics | 2006 |
Calcium Channelopathies
R Felix |
NeuroMolecular Medicine | 2006 |
K(ATP) channel therapeutics at the bedside
A Jahangir, A Terzic |
Journal of Molecular and Cellular Cardiology | 2005 |
Carbonic anhydrase inhibitors ameliorate the symptoms of hypokalaemic periodic paralysis in rats by opening the muscular Ca2+-activated-K+channels
D Tricarico, A Mele, DC Camerino |
Neuromuscular Disorders | 2005 |
From Neuroscience To Neurology
C Massicotte, SS Scherer |
From Neuroscience To Neurology | 2005 |
Carbonic anhydrase inhibitors are specific openers of skeletal muscle BK channel of K+-deficient rats
D Tricarico |
The FASEB Journal | 2004 |
Paralisia periódica hipocalêmica tirotóxica, uma urgência endócrina: revisão do quadro clínico e genético de 25 pacientes
MR da Silva, MI Chiamolera, TS Kasamatsu, JM Cerutti, RM Maciel |
Arquivos brasileiros de endocrinologia e metabologia | 2004 |
Calcium Channel Pharmacology
SI McDonough |
2004 | |
Dualistic actions of cromakalim and new potent 2H-1,4-benzoxazine derivatives on the native skeletal muscle K ATP channel
D Tricarico, M Barbieri, L Antonio, P Tortorella, F Loiodice, DC Camerino |
British Journal of Pharmacology | 2003 |
Involvement of 3Na+/2K+ ATP-ase and Pi-3 kinase in the response of skeletal muscle ATP-sensitive K+ channels to insulin
D Tricarico, L Montanari, DC Camerino |
Neuromuscular Disorders | 2003 |
K ATP channels depress force by reducing action potential amplitude in mouse EDL and soleus muscle
B Gong, D Legault, T Miki, S Seino, JM Renaud |
American journal of physiology. Cell physiology | 2003 |
Dysferlin expression in tubular aggregates: their possible relationship to endoplasmic reticulum stress
K Ikezoe, H Furuya, Y Ohyagi, M Osoegawa, I Nishino, I Nonaka, J Kira |
Acta Neuropathologica | 2003 |
Periodic paralysis: Understanding channelopathies
F Lehmann-Horn, K Jurkat-Rott, R Rüdel |
Current Neurology and Neuroscience Reports | 2002 |
An expanding view for the molecular basis of familial periodic paralysis
SC Cannon |
Neuromuscular Disorders | 2002 |
Tricyclic antidepressants and fibromyalgia: what is the mechanism of action?
K Lawson |
Expert Opinion on Investigational Drugs | 2002 |
Genetic disorders of neuromuscular ion channels
KA Kleopa, RL Barchi |
Muscle & Nerve | 2002 |
Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis
MR da Silva, JM Cerutti, CH Tengan, GK Furuzawa, TC Vieira, AA Gabbai, RM Maciel |
Clinical Endocrinology | 2002 |
Thyrotoxicosis and Paraparesis in a Young Woman: Case Report and Review of the Literature
G Mellgren, IH Bleskestad, S Aanderud, L Bindoff |
Thyroid | 2002 |
Disruption of Sur2-containing K(ATP) channels enhances insulin-stimulated glucose uptake in skeletal muscle
WA Chutkow, V Samuel, PA Hansen, J Pu, CR Valdivia, JC Makielski, CF Burant |
Proceedings of the National Academy of Sciences | 2001 |
Voltage-gated ion channelopathies of the nervous system
S Cannon |
Clinical Neuroscience Research | 2001 |
Peripheral channelopathies as targets for potassium channel openers
K Lawson, MJ Dunne |
Expert Opinion on Investigational Drugs | 2001 |
The skeletal muscle channelopathies: basic science, clinical genetics and treatment
NP Davies, MG Hanna |
Current Opinion in Neurology | 2001 |
Inherited muscle and brain channelopathies
NP Davies, MG Hanna |
Expert Review of Neurotherapeutics | 2001 |
Ion channels in muscle and cardiac hereditary diseases: from gene dysfunction to pharmacological therapy
JF Desaphy, AD Luca, D Tricarico, S Pierno, DC Camerino |
Neuromuscular Disorders | 2001 |
Mutations in Kir2.1 Cause the Developmental and Episodic Electrical Phenotypes of Andersen's Syndrome
NM Plaster, R Tawil, M Tristani-Firouzi, S Canún, S Bendahhou, A Tsunoda, MR Donaldson, ST Iannaccone, E Brunt, R Barohn, J Clark, F Deymeer, AL George, FA Fish, A Hahn, A Nitu, C Ozdemir, P Serdaroglu, SH Subramony, G Wolfe, YH Fu, LJ Ptáček |
Cell | 2001 |
Skeletal muscle sodium current is reduced in hypokalemic periodic paralysis
RL Ruff |
Proceedings of the National Academy of Sciences | 2000 |
Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current
K Jurkat-Rott, N Mitrovic, C Hang, A Kouzmekine, P Iaizzo, J Herzog, H Lerche, S Nicole, J Vale-Santos, D Chauveau, B Fontaine, F Lehmann-Horn |
Proceedings of the National Academy of Sciences | 2000 |
Channelopathies
C Fahlke |
Channelopathies | 2000 |
Channelopathies: Potassium-Related Periodic Paralyses and Similar Disorders
EF Bond |
AACN Clinical Issues: Advanced Practice in Acute & Critical Care | 2000 |
Acetazolamide opens the muscular KCa2+ channel: A novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis
D Tricarico, M Barbieri, DC Camerino |
Annals of Neurology | 2000 |
Acetazolamide opens the muscular KCa2+ channel: a novel mechanism of action that may explain the therapeutic effect of the drug in hypokalemic periodic paralysis
D Tricarico, M Barbieri, D C Camerino |
Annals of Neurology | 2000 |
A K ATP channel deficiency affects resting tension, not contractile force, during fatigue in skeletal muscle
B Gong, T Miki, S Seino, JM Renaud |
American journal of physiology. Cell physiology | 2000 |
Neurological channelopathies: diagnosis and therapy in the new millennium
NP Davies, MG Hanna |
Annals of Medicine | 1999 |
Effects of mutations causing hypokalaemic periodic paralysis on the skeletal muscle L-type Ca 2+ channel expressed in Xenopus laevis oocytes
JA Morrill, SC Cannon |
The Journal of Physiology | 1999 |
Advances in Genetics
BH Bowman, F Yang, GS Adrian |
Advances in genetics | 1988 |